CJC-1295 / IPA
CJC-1295 / IPA is a research peptide combination composed of CJC-1295, a growth hormone–releasing hormone (GHRH) analog, and Ipamorelin (IPA), a selective growth hormone secretagogue receptor (GHS-R) agonist. At Dobtry Peptides, this combination is supplied exclusively for laboratory research and in-vitro scientific investigation.
This dual-peptide formulation is widely utilized in experimental models examining growth hormone signaling dynamics, endocrine system regulation, and pulsatile secretion pathways. The complementary mechanisms of CJC-1295 and Ipamorelin provide researchers with a robust platform for studying coordinated hormonal signaling under controlled laboratory conditions.
Overview
CJC-1295 is designed to stimulate endogenous growth hormone release by acting on GHRH receptors, extending the signaling duration through increased receptor interaction stability. Ipamorelin selectively activates ghrelin receptors, promoting growth hormone secretion while minimizing interaction with other endocrine pathways.
When studied together, CJC-1295 and Ipamorelin are commonly used in research models to analyze synergistic growth hormone signaling, receptor responsiveness, and endocrine rhythm modulation without direct hormonal replacement.
- Supports investigation of growth hormone signaling pathways
- Widely studied in endocrine and metabolic research models
- Combines GHRH analog and GHS-R agonist mechanisms
- Non-steroidal and non-anabolic research peptides
- Suitable for in-vitro and preclinical laboratory investigations
Specifications
- Peptide Components: CJC-1295 and Ipamorelin (IPA)
- CJC-1295 Type: GHRH analog
- Ipamorelin Type: Growth hormone secretagogue receptor agonist
- Research Type: Endocrine and growth hormone signaling model
- Alternate Names: CJC-1295 / Ipamorelin, GH Research Peptide Combination
Research Insights
Growth Hormone Signaling Dynamics
Research involving CJC-1295 / IPA focuses on the regulation of endogenous growth hormone release and receptor-mediated signaling pathways. Experimental models examine pulse amplitude, frequency, and duration of GH secretion.
Endocrine Regulation Models
This peptide combination is commonly used to study hypothalamic–pituitary axis function, hormonal feedback mechanisms, and endocrine signaling coordination under controlled laboratory settings.
Selective Receptor Interaction
Ipamorelin is studied for its selectivity toward ghrelin receptors, while CJC-1295 enhances GHRH receptor signaling. Together, they provide a precise model for analyzing receptor-specific endocrine responses.
Metabolic and Cellular Research Applications
CJC-1295 / IPA is frequently incorporated into research exploring metabolic regulation, cellular signaling pathways, and hormone-responsive biological systems.
Usage & Handling
CJC-1295 / IPA from Dobtry Peptides is supplied strictly for laboratory research and in-vitro use only. This product is not intended for human or animal consumption and is not approved for therapeutic, diagnostic, or clinical applications. All handling, storage, and experimental procedures must comply with institutional laboratory safety standards.
Notice: For research use only. Not for human or animal consumption.
Reviews
There are no reviews yet.